Overview
Thoas Fioretos practices in Lund, Sweden. Fioretos is rated as an Experienced expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Chronic Myelogenous Leukemia (CML).
Their clinical research consists of co-authoring 86 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- LeukemiaFioretos isDistinguished. Learn about Leukemia.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Fioretos isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chromosome 13q DeletionFioretos isAdvanced. Learn about Chromosome 13q Deletion.
- Chronic Myelogenous Leukemia (CML)
- Experienced
- Adult Soft Tissue SarcomaFioretos isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaFioretos isExperienced. Learn about Adult T-Cell Leukemia.
- Bladder CancerFioretos isExperienced. Learn about Bladder Cancer.
- Burkitt LymphomaFioretos isExperienced. Learn about Burkitt Lymphoma.
- ChondroblastomaFioretos isExperienced. Learn about Chondroblastoma.
- MosaicismFioretos isExperienced. Learn about Mosaicism.